Text
Advances in Multiple Sclerosis Research-Series I
Designing immunotherapeutics, drugs, and anti-inflammatory reagents has been at the
forefront of autoimmune research, in particular, multiple sclerosis, for over 20 years. Delivery methods
that are used to modulate effective and long-lasting immune responses have been the major focus.
This Special Issue, “Advances in Multiple Sclerosis Research—Series I”, focused on delivery methods
used for immunotherapeutic approaches, drug design, anti-inflammatories, identification of markers,
methods for detection and monitoring MS and treatment modalities
No copy data
No other version available